NCT Number: NCT02397642
Dual Trigger Versus Booster Dose of HCG
To salvage the luteal phase and improve pregnancy rate in antagonist IVF/ICSI cycles triggered with GnRH agonist. Two strategies are compared dual trigger with GnRH agonist plus 1000 IU of HCG or triggering with GnRH and giving a booster dose of HCG (1500 IU) on the day of ovum pickup.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–37 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
IVF centre, Obstetrics and Gynaecology Department, Cairo University Hospitals (Kasr EL Aini), Cairo, Egypt
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- High responder females undergoing antagonist protocol IVF/ICSI cycle
- More than 14 MII oocytes
- Estradiol more than 3500 pg/ml on day of trigger
Exclusion criteria
- Any other protocol
- Normal or poor responders
Treatment and study plan
Human Chorionic Gonadotropin
Druggiven in different doses and timing to support the luteal phase
Primary outcomes
-
Clinical pregnancy rate
Time frame: 1 year
The number of cycles with a evidence of a gestational sac with fetal pulstaions after 5 weeks from pregnancy test
Secondary outcomes
-
OHSS rate
Time frame: 1 year
The number of cycles with evidence of OHSS
Other outcomes
-
Chemical pregnancy rate
Time frame: 1 year
The numbr of cycles with a positive pregnancy test after 14 days from embryo transfer
-
Early miscarriage rate
Time frame: 1 year
Pregnancies ending with miscarriage before 12 weeks of gestation
-
Ongoing pregnancy rate
Time frame: 1 year
Pregnancies ongoing beyond 12 weeks of gestation
-
Live birth rate
Time frame: 1 year
Pregnancies ending in a live birth
Sponsors and collaborators
Lead sponsor
Cairo University
Other
Collaborators
- Adam International Hospital
- Nile Ivf Center, Cairo, Egypt
Registry information
Official study title
Dual Trigger Versus Booster Dose of HCG on Ovum Pickup Day in Antagonist IVF/ICSI Cycles Triggered With GnRH Agonist in High Responder Females to Salvage the Luteal Phase
Important dates
- Study start
- 2015
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Mar 25, 2015
- Registry last updated
- Jan 29, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsEvaluation of the Uterine Cavity After Operative Hysteroscopy
NCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsHormonal Regulation of Puberty and Fertility
NCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsClinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
NCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details